SGP
SpyGlass Pharma, Inc.
24.60$
+3.0%
vs. previous close
Closing price · As of: Oct 8, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q4 24 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 74.6% | 94.2% | 93.9% | 98.1% | 97.1% | |
| 69.8% | 83.5% | 83.2% | 92.5% | 91.7% | |
| – | 92.9% | 92.7% | 97.1% | 96.2% | |
| – | 0.3% | 0.4% | 0.3% | 0.3% | |
| 359.3% | 168.7% | 185.3% | 3.2% | 4.5% | |
| 33.4% | 5.2% | 7.4% | 2.6% | 3.9% | |
| – | 0.4% | – | – | – | |
| 8.5% | 1.3% | 2.3% | 1.4% | 1.7% | |
| -259.3% | -68.7% | -85.3% | 96.8% | 95.5% | |
| -278.2% | -72.6% | -90.4% | -45.9% | -56.9% | |
| 136.9% | 26.3% | 28.8% | 7.7% | 13.7% |
Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.